Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | CFTR | P13569 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | FAAH | O00519 | 2/20 | 0.49 |
| ▸ | KDR | P35968 | 1/20 | 0.49 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.49 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.49 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.47 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.47 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29750532 | 1.00 | MGAM (0.57) | MGAMRAB9ACFTRKDM4EKMT2A | |
| SCHEMBL12505006 | 0.85 | MGAM (0.57) | MGAMRAB9ACFTRKDM4EALDH1A1 | |
| SCHEMBL529902 | 0.85 | MGAM (0.51) | MGAMRAB9ACFTRKDM4EKMT2A | |
| SCHEMBL2846347 | 0.83 | MGAM (0.54) | MGAMRAB9ACFTRFAAHKDR | |
| SCHEMBL6276150 | 0.83 | PDGFRB (0.49) | MGAMRAB9ACFTRKDM4EKMT2A | |
| Hydrochloric Acid SCHEMBL3867467 | 0.82 | MGAM (0.53) | MGAMRAB9ACFTRKDM4EFAAH | |
| SCHEMBL6597946 | 0.82 | CYP1A2 (0.52) | MGAMRAB9ACFTRKDM4EKMT2A | |
| SCHEMBL6239112 | 0.81 | KDM4E (0.55) | MGAMRAB9AKDM4EKMT2AMEN1 | |
| SCHEMBL5199025 | 0.81 | CYP1A2 (0.60) | MGAMRAB9ACFTRFAAHHDAC3 | |
| SCHEMBL5856432 | 0.81 | CYP1A2 (0.52) | MGAMRAB9ACFTRKDM4EKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025243208-A2 | PROCESS FOR THE PREPARATION AND/OR PURIFICATION OF POLYETHYLENE GLYCOL AND ITS DERIVATIVES, OBTAINED PRODUCT AND USES THEREOF | HOVIONE - FARMACIÊNCIA, SA (PT) | 2025-11-27 | — | — | WO | claimed |
| CN-117003553-A | Corrosion-resistant composite refractory material and preparation method thereof | 济源市耐火炉业有限公司 | 2023-11-07 | — | — | CN | claimed |
| CN-113248421-B | Preparation method of nifedipine | 合肥立方制药股份有限公司 | 2022-03-08 | — | — | CN | claimed |
| CN-113248421-A | Preparation method of nifedipine | 合肥立方制药股份有限公司 | 2021-08-13 | — | — | CN | claimed |
| CN-112939748-A | Method for preparing deuterated compound through decarboxylation and deuteration of carboxylic acid | 中国科学院大连化学物理研究所 | 2021-06-11 | — | — | CN | claimed |
| CN-112867504-A | Novel control switch | 葛兰素史克知识产权开发有限公司 | 2021-05-28 | — | — | CN | claimed |
| US-10806734-B2 | Functional cure of retroviral infection | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2020-10-20 | — | — | US | claimed |
| CN-108396325-B | Water-soluble weldable nickel protective agent | 广州天至环保科技有限公司 | 2020-07-03 | — | — | CN | claimed |
| CN-111253304-A | Preparation method of nifedipine | 合肥立方制药股份有限公司 | 2020-06-09 | — | — | CN | claimed |
| WO-2020078925-A1 | NOVEL CONTROL SWITCH | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2020-04-23 | — | — | WO | claimed |
| CN-108396325-A | A kind of solderable nickel protective agent of water solubility | 广州天至环保科技有限公司 | 2018-08-14 | — | — | CN | claimed |
| CN-105143190-A | Substituted naphthyridine and quinoline compounds as MAO inhibitors | DART NEUROSCIENCE LLC | 2015-12-09 | — | — | CN | claimed |
| CN-1694873-A | Vanilloid receptor ligands and their use in treatments | AMGEN INC (US) | 2005-11-09 | — | — | CN | claimed |
| EP-0633261-B1 | QUINOLINE-3-ACETIC ACID DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF | YOSHITOMI PHARMACEUTICAL (JP) | 1999-04-21 | — | — | EP | claimed |
| US-5543420-A | ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AGENTS; PREVENTION OF ACCUMULATION OF SORBITOL AND GALACTITOL IN MAMMALIAN TISSUE | THE GREEN CROSS CORPORATION (JP) | 1996-08-06 | — | — | US | claimed |
| CN-1102040-A | Quinoline-3-acetic acid derivative, process for producing the same, and use thereof | GREEN CROSS CORP (JP) | 1995-04-26 | — | — | CN | claimed |
| EP-0633261-A1 | QUINOLINE-3-ACETIC ACID DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF | THE GREEN CROSS CORPORATION (JP) | 1995-01-11 | — | — | EP | claimed |
| WO-2025243208-A2 | PROCESS FOR THE PREPARATION AND/OR PURIFICATION OF POLYETHYLENE GLYCOL AND ITS DERIVATIVES, OBTAINED PRODUCT AND USES THEREOF | HOVIONE - FARMACIÊNCIA, SA (PT) | 2025-11-27 | — | — | WO | disclosed |
| WO-1993009132-A1 | HIV PROTEASE INHIBITORS CONTAINING GUANIDINE | SMITHKLINE BEECHAM CORPORATION (US) | 1993-05-13 | — | — | WO | disclosed |
| CN-85106674-A | The preparation method of 2-hydroxy quinoline carboxylic acid derivatives | — | 1986-07-16 | — | — | CN | disclosed |